SIGN UP
LOG IN
MARKET
ICLR
ICLR
ICON PLC
NASDAQ
266.94
-0.05
-0.02%
After Hours: 266.25 -0.69 -0.26% 16:46 11/30 EST
OPEN
265.86
PREV CLOSE
266.99
HIGH
268.30
LOW
263.15
VOLUME
721.15K
TURNOVER
0
52 WEEK HIGH
276.68
52 WEEK LOW
181.92
MARKET CAP
21.98B
P/E (TTM)
43.00
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ICLR last week (1120-1124)?
Weekly Report · 3d ago
ICON: Starting Valuations And Business Returns Are 2 Major Hurdles
Iclr's q3 numbers indicate the market is forecasting a period of better business for the company in 2024. Projected earnings growth out to 2025 is 9-14% on sales growth of 5-7%. Despite a strong company, current multiples are expensive. Icon is a hold because of its valuation and lack of business returns.
Seeking Alpha · 4d ago
ICON (NASDAQ:ICLR) shareholders have earned a 14% CAGR over the last five years
Icon public limited company's share price is up 92% in the last 5 years, besting the market return of 62%. Icon has a total shareholder return of 25% over the last 12 months. The company has grown its earnings per share at 2.0% a year, but not at the rate of the market. Icon's earnings growth does not match the performance of the company's underlying business.
Simply Wall St · 11/23 18:39
ICON PLC: Report of proposed sale of securities
Press release · 11/22 02:00
3 Reasons Growth Investors Will Love Icon PLC (ICLR)
NASDAQ · 11/20 17:45
Weekly Report: what happened at ICLR last week (1113-1117)?
Weekly Report · 11/20 09:20
ICON PLC: Report of proposed sale of securities
Press release · 11/17 01:00
Analysts Offer Insights on Healthcare Companies: Icon (ICLR), Becton Dickinson (BDX) and McKesson (MCK)
3 analysts have maintained buy ratings on icon (iclr), becton dickinson (bdx) and mckesson. Jefferies analyst david windley maintained a buy rating on icon yesterday. Bect on dickinson has also been reiterated as a buy in a report released by jefferies.
TipRanks · 11/15 13:30
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors. Its sectors include Biosimilars, Biotech, Government and public health solutions, medical devices, pharmaceuticals and the IVDR journey.
Webull offers ICON PLC stock information, including NASDAQ: ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.